These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4317444)

  • 1. [The disinfectant activity of iosan against foot and mouth disease virus].
    Böhm HO
    Dtsch Tierarztl Wochenschr (1946); 1970 Aug; 77(15):377-82. PubMed ID: 4317444
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of chemical agents on foot-and-mouth disease virus production in cell cultures.
    Polatnick J
    Am J Vet Res; 1965 Sep; 26(114):1051-5. PubMed ID: 4287298
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of alkylating agents for the inactivation of foot-and-mouth disease virus and the preparation of a new inactivated vaccine].
    Durand M; Guilloteau B; Giraud M; Guerche M; Pesson M; Prunet P
    Bull Off Int Epizoot; 1968; 69(3):429-65. PubMed ID: 4303692
    [No Abstract]   [Full Text] [Related]  

  • 4. Actinomycetes activity against foot and mouth disease virus determined by a new method.
    De Banchero EP; Goyena JG; Cercos AP
    J Antibiot (Tokyo); 1965 Jul; 18(4):195. PubMed ID: 4285352
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of foot-and-mouth disease virus inhibitors in cell cultures and experimental animals].
    Tekerlekov P; Mitev G; Andonov P; Dundarov S; Bakalov B
    Vet Med Nauki; 1976; 13(10):60-6. PubMed ID: 193238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of pretreatment by immunity adjuvants on the multiplication of foot-and-mouse disease virus in adult mouse].
    Gorhe D; Asso J; Paraf A
    Ann Inst Pasteur (Paris); 1968 Sep; 115(3):446-64. PubMed ID: 4304117
    [No Abstract]   [Full Text] [Related]  

  • 7. Hydroxylamine as an inactivating agent for foot-and-mouth disease virus.
    Fellowes ON
    J Immunol; 1966 May; 96(5):772-6. PubMed ID: 4288021
    [No Abstract]   [Full Text] [Related]  

  • 8. Some experiences with chemical inactivants of foot-and-mouth disease virus.
    Fellowes ON
    J Immunol; 1967 Sep; 99(3):508-13. PubMed ID: 4293089
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of temperature and inactivators on strains of foot-and-mouth disease virus in Colombia].
    Gómez GJ; Doel TR
    Rev Latinoam Microbiol; 1984; 26(1):21-6. PubMed ID: 6091209
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the inactivation and antigenicity of foot-and-mouth-disease virus by acetylethyleneimine and by combined effect of ultraviolet light and beta-propiolactone.
    Fellowes ON
    J Immunol; 1965 Dec; 95(6):1100-6. PubMed ID: 4285068
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of vaccination against foot-and-mouth disease on results of the immunodiffusion test for the demonstration of precipitating bovine leukosis virus antibodies].
    Straub OC
    Dtsch Tierarztl Wochenschr; 1983 Apr; 90(4):135-7. PubMed ID: 6305624
    [No Abstract]   [Full Text] [Related]  

  • 12. [Field observations concerning airborne transmission of foot-and-mouth disease virus].
    Bischofberger A
    Schweiz Arch Tierheilkd; 1972 Mar; 114(3):167-209. PubMed ID: 4339496
    [No Abstract]   [Full Text] [Related]  

  • 13. [Serologic and immunologic studies of the subtypes of foot-and-mouth disease virus. Influence of booster vaccination].
    Moreau Y; Perrenot F; Chappuis G; Terré J; Fontaine J
    Bull Off Int Epizoot; 1971; 75(3):99-114. PubMed ID: 4327833
    [No Abstract]   [Full Text] [Related]  

  • 14. Investigation of disinfectants for foot-and-mouth disease in the Republic of Korea.
    Kim HM; Shim IS; Baek YW; Han HJ; Kim PJ; Choi K
    J Infect Public Health; 2013 Oct; 6(5):331-8. PubMed ID: 23999336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proceedings: Quantitative assay of the immunizing dose of monovalent vaccines against foot-and-mouth disease prepared from the virus propagated on cattle tongue mucosa and in culture after Frenkel.
    Wiśniewski J; Kobusiewicz T; Szkilnik S; Baranowski C; Jankowska J; Labecka W
    Acta Microbiol Pol A; 1974; 6(1):131. PubMed ID: 4364054
    [No Abstract]   [Full Text] [Related]  

  • 16. The inactivation of foot-and mouth disease virus by chemicals and disinfectants.
    Sellers RF
    Vet Rec; 1968 Nov; 83(20):504-6. PubMed ID: 4301329
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of the antiviral activity of pancreatic and microbial RNAse].
    Alekseeva II; Kurinenko BM; Kleiner GI; Skuia AZh; Penzikova GA
    Antibiotiki; 1981 Jul; 26(7):527-32. PubMed ID: 6267996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an effective vaccine against foot-and-mouth disease with partially purified and concentrated virus antigen.
    Sen AK; Saha SN
    Acta Virol; 1994 Feb; 38(1):17-9. PubMed ID: 8067308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foot-and-mouth disease.
    Br Med J; 1967 Dec; 4(5581):694-5. PubMed ID: 4293988
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate.
    Mason PW; Piccone ME; Mckenna TS; Chinsangaram J; Grubman MJ
    Virology; 1997 Jan; 227(1):96-102. PubMed ID: 9007062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.